A new Deep Research AI agent called Bioptic Agent has achieved 79.7% F1 score in a drug asset scouting benchmark, significantly outperforming leading models like Claude Opus 4.6 (56.2%), GPT-5.2 Pro (46.6%), Gemini 3 Pro + Deep Research (50.6%), and others. The Problem: Drug Asset Scouting in a Connected World …